Lupin Stock rises after Lupin receives FDA approval for Tolvaptan tablets
Lupin Stock rises: The U.S. Food and Drug Administration has given the pharmaceutical company Lupin preliminary clearance for its abbreviated new drug application (ANDA) for Tolvaptan tablets, 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg. The drug, a generic version of the Jynarque 15 mg, 30 mg, 45 mg, 60 mg, and … Read more